Journal article
RACK1 binds to a signal transfer region of G betagamma and inhibits phospholipase C beta2 activation
The Journal of biological chemistry, Vol.280(39), pp.33445-33452
09/30/2005
DOI: 10.1074/jbc.M505422200
PMID: 16051595
Abstract
Receptor for Activated C Kinase 1 (RACK1), a novel G betagamma-interacting protein, selectively inhibits the activation of a subclass of G betagamma effectors such as phospholipase C beta2 (PLCbeta2) and adenylyl cyclase II by direct binding to G betagamma (Chen, S., Dell, E. J., Lin, F., Sai, J., and Hamm, H. E. (2004) J. Biol. Chem. 279, 17861-17868). Here we have mapped the RACK1 binding sites on G betagamma. We found that RACK1 interacts with several different G betagamma isoforms, including G beta1gamma1, Gbeta1gamma2, and Gbeta5gamma2, with similar affinities, suggesting that the conserved residues between G beta1 and G beta5 may be involved in their binding to RACK1. We have confirmed this hypothesis and shown that several synthetic peptides corresponding to the conserved residues can inhibit the RACK1/G betagamma interaction as monitored by fluorescence spectroscopy. Interestingly, these peptides are located at one side of G beta1 and have little overlap with the G alpha subunit binding interface. Additional experiments indicate that the G betagamma contact residues for RACK1, in particular the positively charged amino acids within residues 44-54 of G beta1, are also involved in the interaction with PLCbeta2 and play a critical role in G betagamma-mediated PLCbeta2 activation. These data thus demonstrate that RACK1 can regulate the activity of a G betagamma effector by competing for its binding to the signal transfer region of G betagamma.
Details
- Title: Subtitle
- RACK1 binds to a signal transfer region of G betagamma and inhibits phospholipase C beta2 activation
- Creators
- Songhai Chen - Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600, USA. Songhai.Chen@Vanderbilt.eduFang LinHeidi E Hamm
- Resource Type
- Journal article
- Publication Details
- The Journal of biological chemistry, Vol.280(39), pp.33445-33452
- DOI
- 10.1074/jbc.M505422200
- PMID
- 16051595
- NLM abbreviation
- J Biol Chem
- ISSN
- 0021-9258
- eISSN
- 1083-351X
- Publisher
- United States
- Language
- English
- Date published
- 09/30/2005
- Academic Unit
- Anatomy and Cell Biology; Iowa Neuroscience Institute; Craniofacial Anomalies Research Center; Fraternal Order of Eagles Diabetes Research Center; Neuroscience and Pharmacology; Internal Medicine
- Record Identifier
- 9984040579502771
Metrics
21 Record Views